OakChart

Aptargroup Inc

ATRHealthcare·Medical Instruments & Supplies·USA·Mid·NYSE·Nov 11 • 12:33 PM ET

142.62-1.50 (-1.04%)
2026-11-11 18:33 CET
Market cap
9,135.62 USD m
Revenue, TTM
3,991.23 USD m
Net income, TTM
267.19 USD m
Free cash flow, TTM
294.69 USD m
EPS diluted, TTM
4.12
P/E
34.59
Compare

Price

ATR against its 20, 50 and 200-day averages
2050200beatmiss
110.00120.00130.00140.00150.00504K1.0MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ATRclose 142.6220-day 133.9250-day 127.51200-day 127.70142.6252w high52w low

4.0% under the 52-week high of 148.63 on 5 Nov 2026. 52-week low 110.95 on 8 Jun 2026. Last 15 sessions, 19.1% high to low

Profile

ATR
52-week range, 84% of the way up
110.95148.63

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty, Closures, and Corporate and Other. The Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions, pharma packaging, and services to the prescription drug industry. The Beauty segment refers to dispensing systems and sealing solutions to the beauty, personal care and home care markets. The Closures segment is involved with dispensing closures, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and other markets. The company was founded in 1940 and is headquartered in Crystal Lake, IL.

IndexRUI
Employees14000
IPOApr 23, 1993
Beta0.32
ATR, 14d3.58
Rel volume0.51
Short float3.40%
Insider own1.87%
Inst own97.96%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap9.04B
Enterprise Value10.29B
Income267.19M
Sales3.99B
Book/sh41.24
Cash/sh3.36
Dividend Est.1.94 (1.36%)
Dividend TTM1.44 (1.01%)
Dividend Ex-DateNov 12, 2026
Dividend Gr. 3/5Y6.38% 4.91%
Payout31.11%
Employees14000
IPOApr 23, 1993

Ratios

P/E34.59
Forward P/E23.00
PEG3.74
P/S2.27
P/B3.46
P/C42.46
P/FCF30.68
EV/EBITDA12.99
EV/Sales2.58
Quick Ratio1.03
Current Ratio1.50
Debt/Eq0.54
LT Debt/Eq0.41
Option/ShortYes / Yes

Earnings

EPS (ttm)4.12
EPS next Y6.20
EPS next Q1.42
EPS this Y-3.33%
EPS next Y11.77%
EPS next 5Y6.15%
EPS past 3/5Y17.89% 12.87%
Sales past 3/5Y4.37% 5.22%
EPS Y/Y TTM-34.33%
Sales Y/Y TTM8.97%
EPS Q/Q-73.53%
Sales Q/Q6.03%
EarningsOct 29 AMC
EPS/Sales Surpr.3.34% 3.91%

Ownership

Insider Own1.87%
Insider Trans-3.38%
Inst Own97.96%
Inst Trans1.24%
ROA5.23%
ROE9.93%
ROIC7.26%
Gross Margin28.09%
Oper. Margin12.14%
Profit Margin6.69%
SMA206.49%
SMA5011.85%
SMA20011.68%
Trades-

Technical

Shs Outstand63.40M
Shs Float62.20M
Short Float3.40%
Short Ratio4.52
Short Interest2.11M
52W High148.63 -4.05%
52W Low110.95 28.54%
Volatility3.02% 2.39%
ATR (14)3.58
RSI (14)67.61
Beta0.32
Rel Volume0.51
Avg Volume467.12K
Volume118,694

Performance

Perf Week-2.89%
Perf Month19.63%
Perf Quarter7.58%
Perf Half Y20.98%
Perf YTD16.94%
Perf Year20.58%
Perf 3Y13.44%
Perf 5Y9.85%
Perf 10Y98.49%
Recom1.82
Target Price163.86
Prev Close144.12
Price142.62
Change %-1.04%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 07, 2026InitiatedDDeutsche BankBuy$150+5.2%
Jul 14, 2026UpgradeBBofA SecuritiesNeutral → Buy$173+21.3%
Mar 20, 2026UpgradeWWells FargoEqual Weight → Overweight$144+1.0%
Jan 06, 2026DowngradeWWells FargoOverweight → Equal Weight$133-6.7%
Nov 03, 2025DowngradeWWilliam BlairOutperform → Mkt Perform
Sep 04, 2025InitiatedKKeyBanc Capital MarketsOverweight$220+54.3%
Jan 07, 2025InitiatedRRaymond JamesOutperform$200+40.2%
Jan 06, 2025DowngradeBBofA SecuritiesBuy → Neutral$173+21.3%
Oct 14, 2024UpgradeJJefferiesHold → Buy$155 → $215+50.8%
Apr 29, 2024UpgradeWWilliam BlairMkt Perform → Outperform

Peers

Mkt cap
TickerCompanyMkt cap
WSTWest Pharmaceutical Services Inc28.84B
STVNStevanato Group Spa3.83B
BDXBecton Dickinson & Co57.51B
SLGNSilgan Holdings Inc4.34B
AMCRAmcor Plc20.51B
TRSTrimas Corp1.35B
SONSonoco Products Co4.89B
CCKCrown Holdings Inc13.10B
BALLBall Corp16.99B
GPKGraphic Packaging Holding Co3.28B

Insider trading

latest 14 of 30
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Prieur MarcSegment PresidentNov 02 '26Sale141.992,000283,97413,823Nov 03 04:22 PM
Prieur MarcOfficerNov 02 '26Proposed Sale137.002,000274,000Nov 02 07:39 AM
Vinczeller ShielaChief Human Resources OfficerSep 02 '26Sale130.3776599,73326,313Sep 03 12:23 PM
SHIELA PALLERNE VINCZELLEROfficerSep 02 '26Proposed Sale130.3776599,733Sep 02 04:10 PM
Touya GaelSegment Pres., CEO DesignateAug 27 '26Sale133.763,740500,27629,102Aug 28 10:10 AM
GAEL TOUYAOfficerAug 27 '26Proposed Sale133.763,740500,276Aug 27 04:18 PM
Prieur MarcSegment PresidentAug 04 '26Sale136.263,500476,89715,823Aug 05 05:50 PM
Tanda Stephan B.President and CEOAug 03 '26Option Exercise74.799,838735,784248,567Aug 04 10:37 AM
Tanda Stephan B.President and CEOAug 03 '26Sale136.169,8381,339,588238,729Aug 04 10:37 AM
Prieur MarcOfficerAug 04 '26Proposed Sale136.003,500476,000Aug 04 06:38 AM
Tlili HediSegment PresidentAug 03 '26Sale135.008,8541,195,29015,379Aug 03 07:55 PM
STEPHAN B TANDADirectorAug 03 '26Proposed Sale136.169,8381,339,588Aug 03 04:19 PM
HEDI TLILIOfficerAug 03 '26Proposed Sale135.008,8551,195,425Aug 03 04:10 PM
Prieur MarcSegment PresidentJun 09 '26Sale115.585,000577,89519,323Jun 10 03:56 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.48B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
VXFVanguard Extended Market Index ETFAUM: 30.47B
SDYState Street SPDR S&P Dividend ETFAUM: 22.68B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.22B
SPMDState Street SPDR Portfolio S&P 400TM Mid Cap ETFAUM: 18.90B
DFASU.S. Small Cap Portfolio-ETF Class Shares-

News

latest 14 of 206
  • AptarGroup Beats As Sales Reaccelerate, But Earnings Still Shrink And Beauty Remains The Weak Link (Earnings Whispers) +5.02%
  • AptarGroup: Q3 Earnings Snapshot (Associated Press)
  • Aptar Reports Third Quarter 2026 Results (Business Wire)
  • Aptar Increases Quarterly Dividend to $0.50 Per Share (Business Wire)
  • Aptar Taps Pharma Packaging Veteran Virginie Maes as President of its Pharma Business (Business Wire)
  • Loading…
  • Aptar's Last Emergency-Medicine Drag Hits As New CEO Faces First Earnings Test (Earnings Whispers)
  • Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery (Business Wire)
  • AptarGroup Inc (ATR) (Q2 2026) Earnings Call Highlights: Record Sales and Strategic Wins Amid ... (GuruFocus.com)
  • AptarGroup: Q2 Earnings Snapshot (Associated Press)
  • Aptar Reports Second Quarter 2026 Results (Business Wire)
  • Aptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive Year (Business Wire)
  • Aptar Declares Quarterly Dividend (Business Wire)
  • Aptar Releases 2025 Corporate Sustainability Report (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-291.5201.4710.5101,019980.768
2026Q22026-07-301.4201.3541.3641,0271,0097
2026Q12026-04-301.1901.1501.121982.87955.957
2025Q42026-02-051.2501.2291.130962.74878.587
2025Q32025-10-301.6201.5671.920961.13953.517
2025Q22025-07-311.6601.5881.666966.01954.936
2025Q12025-05-011.2001.1551.168887.31898.646
2024Q42025-02-061.5201.2571.486848.09852.266
2024Q32024-10-241.4901.4201.477909.29922.335
2024Q22024-07-251.3701.3581.339910.06930.155
2024Q12024-04-251.2601.1461.232915.45890.335
2023Q42024-02-081.2101.1170.929838.48842.55
2023Q32023-10-251.3901.2701.258893908.535
2023Q22023-07-271.2301.1371.243895.91898.896
2023Q12023-04-270.9500.9030.821860.07829.827
2022Q42023-02-160.9200.7900.888795.91775.578

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY3.9503.9343.6612,8602,875
2020FY3.6403.6243.2122,9292,913
2021FY3.8803.8493.6003,2273,201
2022FY3.7903.6593.5913,3223,307
2023FY4.7804.6854.2483,4873,485
2024FY5.6405.3775.5283,5833,591
2025FY5.7405.7115.8903,7773,689
2026FY-5.549--4,011
2027FY-6.202--4,144
2028FY-6.866--4,332
2029FY-7.750--4,678
2030FY-8.750--4,977

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-30721980.62958.31,006
2026Q4S2026-10-29701978.32958.351,000
2026Q4S2026-10-19701978.32958.351,000
2026Q4S2026-10-14801980.73958.351,000
2026Q4S2026-10-11802980.73958.351,000
2026Q4S2026-10-08803980.73958.351,000
2026Q4S2026-10-06703978.94958.351,000
2026Q4S2026-10-05603979.32958.351,000
2026Q4S2026-09-27603980.629621,000
2026Q4S2026-09-25604980.629621,000
2026Q4S2026-07-31603985.369621,000
2026Q4S2026-07-28602987.58963.181,000
2026Q4S2026-07-15601989.58963.181,012
2026Q4S2026-07-14602989.58963.181,012

Estimate history

EPS, annual3.4062.9983.6613.2123.63.5914.2485.5285.8824.123
Period201720182019202020212022202320242025TTM
EPS, quarterly1.4771.4861.1681.6661.921.131.1211.3640.508
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual2469.2832764.7612859.7322929.343227.2213322.2493487.453582.893777.1813991.23
Period201720182019202020212022202320242025TTM
Sales, quarterly909.291848.088887.305966.009961.131962.736982.8681026.5081019.119
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual61.862.963.86565.565.265.966.564.263.4
Period201720182019202020212022202320242025MRQ
Shares, quarterly66.566.566.165.865.664.263.963.663.4
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue3,991.233,777.183,582.893,487.453,322.253,227.222,929.342,859.732,764.76
Cost of Goods Sold Incl. D&A2,870.152,659.812,491.162,472.642,392.122,305.392,063.122,014.651,984.71
Gross Profit1,121.081,117.371,091.721,014.81930.13921.83866.22845.08780.05
Selling, General and Administrative Excl. Other636.41605.04578.83551.08549.86534.66473.34451.22420.95
Research and Development-105.1096.1092.8093.5099.8092.5082.8075.30
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income484.67512.34512.90463.72380.27387.17392.88393.87359.10
Interest Expense65.7452.7443.9040.4241.0030.3034.7240.2937.80
Unusual Expense69.4412.0914.8858.962.5039.9153.0421.3172.18
Net Income Before Taxes360.67491.38469.76374.82334.70321.65301.15342.07266.02
Income Taxes92.8098.8895.5990.6595.1578.0287.0699.8471.25
Consolidated Net Income267.87392.50374.18284.18239.56243.64214.09242.23194.77
Net Income From Continuing Operations267.19392.79374.54284.49239.29244.10214.04242.20194.75
Net Income267.19392.79374.54284.49239.29244.10214.04242.20194.75
EPS (Recurring)4.926.015.694.873.614.023.773.893.78
EPS (Basic, Before Extraordinaries)4.175.975.654.343.663.723.323.813.12
EPS (Diluted)4.125.885.534.253.593.603.213.663.00
EBITDA792.16799.70776.68712.32613.98622.02613.18588.42530.85
Non-Operating Income (Expense)11.1843.8715.6410.48-2.074.69-3.969.8116.90
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense33.2633.8739.8633.5232.3428.381.574.508.40
Price To Earnings Ratio34.9634.9631.5629.3730.9833.9842.6531.5531.34
Price To Sales Ratio1.952.152.972.372.212.573.112.672.21
Gross Margin28.0929.5830.4729.1028.0028.5629.5729.5528.21
Operating Margin12.1413.5614.3213.3011.4512.0013.4113.7712.99
Net Margin6.6910.4010.458.167.207.567.318.477.04
Shares Outstanding63.4064.2066.5065.9065.2065.5065.0063.8062.90
Market Capitalization9,135.629,135.6210,453.948,131.887,179.938,062.508,859.867,391.245,908.91

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1,019.121,026.51982.87962.74961.13966.01887.30848.09
Cost of Goods Sold Incl. D&A721.74740.63706.68701.09673.28668.90616.54586.13
Gross Profit297.38285.88276.18261.64287.85297.11270.77261.96
Selling, General and Administrative Excl. Other160.16157.74167.56150.95148.76151.14155.28138.51
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income137.22128.14108.63110.69139.09145.97115.49123.45
Interest Expense15.7916.0016.9417.0013.5310.8511.3511.37
Unusual Expense60.390.363.375.333.09-0.032.622.30
Net Income Before Taxes60.33115.0593.7791.52154.13139.71106.02116.07
Income Taxes27.5127.0421.0017.2526.3027.9827.3515.21
Consolidated Net Income32.8288.0172.7774.27127.83111.7378.66100.86
Net Income From Continuing Operations32.6087.5772.6774.34127.93111.7278.80100.94
Net Income32.6087.5772.6774.34127.93111.7278.80100.94
EPS (Recurring)1.171.371.161.191.951.671.191.51
EPS (Basic, Before Extraordinaries)0.511.381.131.141.951.691.191.52
EPS (Diluted)0.511.361.121.131.921.671.171.49
EBITDA212.76207.78184.35187.27214.32215.88181.14190.90
Non-Operating Income (Expense)-0.703.275.463.1631.664.574.496.29
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense8.643.4813.028.118.824.4617.712.07
Price To Earnings Ratio34.9621.4521.4219.5523.0628.6026.8131.56
Price To Sales Ratio1.952.042.112.122.432.902.822.98
Gross Margin29.1827.8528.1027.1829.9530.7630.5230.89
Operating Margin13.4612.4811.0511.5014.4715.1113.0214.56
Net Margin3.208.537.397.7213.3111.578.8811.90
Shares Outstanding63.4063.6063.9064.2065.6065.8066.1066.50
Market Capitalization9,135.627,990.308,113.138,002.928,805.5910,330.759,866.5710,453.94

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments410.14226.68224.14141.73123.67305.21246.97262.08713.30
Short Term Receivables815.43670.63695.86693.72688.23582.73558.43569.63510.43
Inventories537.85461.81513.05486.81441.46379.38375.80381.11337.22
Other Current Assets130.15119.27116.23108.03104.85101.67110.05117.99109.13
Total Current Assets1,893.561,478.381,549.281,430.291,358.211,368.991,291.241,330.811,670.07
Net Property, Plant & Equipment1,742.181,511.361,537.141,402.341,338.331,268.591,160.06991.61867.91
Total Investments and Advances131.03146.2749.2052.3159.4850.098.4025.459.44
Intangible Assets1,333.241,191.031,246.631,261.381,336.501,242.831,054.55967.00539.35
Other Assets152.71105.2469.6457.1448.8459.5547.8862.8751.05
Total Assets5,252.724,432.284,451.894,203.464,141.363,990.053,562.123,377.743,137.82
Short Term Debt Incl. Current Port. of LT Debt361.28355.30472.28139.78304.98136.67126.83163.9766.17
Accounts Payable340.56295.97328.57320.28285.26243.74192.74164.53153.86
Other Current Liabilities464.61417.01450.46457.12392.25399.92363.71360.67307.72
Total Current Liabilities1,166.441,068.281,251.31917.18982.49780.33683.27689.17527.75
Long Term Debt1,187.37737.78726.461,095.55955.031,107.211,140.731,125.991,191.15
Provision for Risks Charges67.6062.2162.8048.98116.81145.96101.2262.3280.28
Deferred Tax Liabilities19.6514.2619.0220.5627.5537.2441.3953.9221.00
Other Liabilities99.4363.8271.0252.9974.8868.5323.2523.465.61
Total Liabilities2,540.491,946.352,130.592,135.252,156.762,139.271,989.871,954.861,825.78
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity2,668.102,471.892,306.822,053.931,969.411,850.391,571.921,422.561,311.74
Total Shareholders Equity2,668.102,471.892,306.822,053.931,969.411,850.391,571.921,422.561,311.74
Accumulated Minority Interest44.1314.0414.4714.2715.190.400.340.320.31
Total Equity2,712.222,485.922,321.302,068.201,984.601,850.791,572.251,422.871,312.05
Total Liabilities & Stockholders Equity5,252.724,432.284,451.894,203.464,141.363,990.053,562.123,377.743,137.82
Book Value Per Share41.5637.1735.0031.5030.0728.4724.6422.6221.23
Tangible Book Value Per Share20.7919.2616.0912.169.669.358.117.2412.50
Full-Time Employees14,00013,50013,80013,50013,00013,00014,00014,10013,200
Price to Book Ratio3.504.113.703.834.074.814.694.164.07
Return on Assets8.118.436.575.746.005.676.985.987.66
Return on Equity15.2815.6813.0511.8912.7812.5116.1814.2417.70
Return on Invested Capital10.1911.679.387.608.357.248.937.648.79
Quick Ratio1.160.950.831.030.931.271.341.382.53
Current Ratio1.621.381.241.561.381.751.891.933.16

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income267.87392.50374.18284.18239.56243.64214.09242.23194.77
Depreciation307.49287.36263.78248.59233.71234.85220.30194.55171.75
Other Funds (Non Cash)118.9527.2859.1256.6062.4669.0067.6240.2332.94
Funds from Operations709.21695.45675.67569.49523.61533.14493.81485.75376.11
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-135.74-125.45-32.265.75-45.00-169.6976.3428.71-62.48
Income Taxes Payable-13.04-9.074.06-8.3017.08-4.63-6.095.66-3.15
Cash from Operating Activities573.47570.00643.41575.24478.62363.44570.15514.46313.63
Capital Expenditures-281.44-275.44-294.19-318.40-315.62-307.94-252.05-247.08-211.86
Net Assets From Acquisitions-32.14-60.200.00-16.57-4.10-148.42-164.18-106.33-527.92
Sale of Fixed Assets and Businesses0.083.551.515.350.095.235.264.304.47
Purchase or Sale of Investments0.09-2.89-101.305.602.34-4.93-39.8712.96-10.00
Purchase of Investments-2.87-8.66-101.300.000.00-7.37-39.87-3.53-10.00
Sale Or Maturity of Investments2.965.770.005.602.342.430.0016.490.00
Other Uses-29.980.00-2.74-0.44-6.15-3.19-1.14-0.120.00
Other Sources-3.560.000.0027.802.000.000.009.85
Cash from Investing Activities-338.50-331.43-396.72-324.46-295.64-457.24-451.98-336.27-735.46
Cash Dividends Paid-123.55-120.78-114.06-103.68-99.46-98.51-92.66-90.21-82.35
Change in Capital Stock-333.95-351.54-13.836.43-63.61-18.2468.564.3426.46
Repurchase of Common Pref Stock-354.97-365.00-68.64-47.55-92.13-78.150.00-86.50-61.69
Sale of Common Pref Stock21.0213.4754.8153.9828.5159.9168.5690.8388.16
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net179.33394.06-97.46-51.550.9836.95-46.85-111.2641.01
Change in Long Term Debt314.14433.64-205.27-125.41142.93-57.14-59.88-56.75-59.13
Issuance of Long Term Debt605.11600.21168.580.40408.0111.704.8510.5213.16
Reduction of Long Term Debt-290.97-166.56-373.85-125.81-265.08-68.84-64.73-67.28-72.29
Net Financing Active Other Cash Flow-2.940.790.00-22.750.00-1.72-2.770.000.00
Other Financing Activities Uses-3.730.000.00-22.750.00-1.72-2.770.000.00
Cash from Financing Activities-281.12-77.47-225.34-171.55-162.10-81.52-73.72-197.13-14.87
Exchange Rate Effect-4.8119.40-21.152.19-1.07-6.7313.54-0.90-9.11
Net Change in Cash-50.96180.500.2081.4119.81-182.0458.00-19.85-445.82
Free Cash Flow294.69299.58366.93262.90168.1955.51324.20272.18102.38
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow45.4145.5142.0551.95106.76-39.4142.03305.07
Deferred Taxes & Investment Tax Credit--11.69-21.41-19.88-12.11-14.36-8.208.75-23.35

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments212.90197.27230.08410.14264.81169.76
Short Term Receivables897.66914.39846.13815.43812.15812.01
Inventories582.61580.14551.48537.85547.30527.42
Other Current Assets143.63143.03140.58130.15159.33153.82
Total Current Assets1,836.791,834.821,768.271,893.561,783.601,663.02
Net Property, Plant & Equipment1,694.821,707.021,722.161,742.181,706.941,651.61
Total Investments and Advances132.87134.75130.76131.03130.35154.10
Intangible Assets1,291.681,303.401,317.071,333.241,327.141,246.38
Other Assets155.47153.22159.52152.71152.82150.26
Total Assets5,111.635,133.215,097.785,252.725,100.854,865.38
Short Term Debt Incl. Current Port. of LT Debt350.68249.24222.17361.28654.57551.52
Accounts Payable788.48807.78759.75340.56760.80694.52
Other Current Liabilities83.6679.5381.12464.6183.82122.84
Total Current Liabilities1,222.811,136.551,063.031,166.441,499.191,368.88
Long Term Debt1,067.671,162.331,187.381,187.37595.23584.71
Provision for Risks Charges67.7966.1464.1467.6075.0272.79
Deferred Tax Liabilities16.4917.2317.2919.6520.4820.81
Other Liabilities75.6876.5391.6999.4398.86100.37
Total Liabilities2,450.442,458.772,423.532,540.492,288.782,147.57
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity2,614.322,628.292,629.492,668.102,769.712,700.12
Total Shareholders Equity2,614.322,628.292,629.492,668.102,769.712,700.12
Accumulated Minority Interest46.8646.1544.7644.1342.3617.69
Total Equity2,661.182,674.452,674.252,712.222,812.072,717.81
Total Liabilities & Stockholders Equity5,111.635,133.215,097.785,252.725,100.854,865.38
Book Value Per Share41.2441.3341.1541.5642.2241.04
Tangible Book Value Per Share20.8620.8320.5420.7921.9922.09
Full-Time Employees---14,000--
Price to Book Ratio3.503.043.032.893.264.07
Return on Assets5.237.258.038.118.628.40
Return on Equity9.9313.6114.9715.2815.8015.36
Return on Invested Capital0.892.311.901.933.803.40
Quick Ratio1.031.101.141.160.820.83
Current Ratio1.501.611.661.621.191.21

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income32.8288.0172.7774.27127.83111.73
Depreciation75.5479.6475.7276.5875.2369.90
Other Funds (Non Cash)73.969.6022.2013.19-14.847.69
Funds from Operations180.16178.72166.13184.19177.70169.86
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-12.57-75.23-47.44-0.50-0.09-43.90
Income Taxes Payable0.51-5.860.10-7.79-0.376.29
Cash from Operating Activities167.60103.49118.69183.69177.61125.96
Capital Expenditures-70.05-57.86-65.99-87.54-63.61-64.96
Net Assets From Acquisitions0.00-0.160.00-31.98-20.29-7.93
Sale of Fixed Assets and Businesses-1.102.331.42-2.572.733.31
Purchase or Sale of Investments-1.35-0.01-0.101.55-7.262.91
Purchase of Investments-1.35-0.01-0.10-1.41-7.260.09
Sale Or Maturity of Investments0.000.000.002.96-0.012.82
Other Uses-29.57-0.07-0.340.000.05-0.05
Other Sources1.35--3.53--
Cash from Investing Activities-100.71-55.77-65.01-117.01-88.35-69.44
Cash Dividends Paid-30.52-30.61-30.92-31.50-29.65-29.72
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-26.56-49.53-81.46-176.40-35.70-62.81
Repurchase of Common Pref Stock-30.00-50.00-99.97-175.00-40.01-70.00
Sale of Common Pref Stock3.440.4718.52-1.404.317.19
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net7.912.71-115.86284.5772.4565.27
Change in Long Term Debt-4.91-26.99-122.89468.93-3.22-27.64
Issuance of Long Term Debt0.051.035.04599.000.320.76
Reduction of Long Term Debt-4.96-28.02-127.93-130.07-3.54-28.40
Net Financing Active Other Cash Flow0.00-1.53-2.200.790.000.00
Other Financing Activities Uses0.00-1.53-2.200.000.000.00
Cash from Financing Activities-49.18-78.97-230.4377.467.11-27.27
Exchange Rate Effect-3.93-0.88-3.153.15-1.046.63
Net Change in Cash13.77-32.13-179.90147.2995.3335.89
Free Cash Flow98.5945.9253.3096.87114.2962.53
Price to Free Cash Flow45.4142.8239.8144.8845.5243.01

Revenue breakdown

China2024: 155.50M 2025: 194.41M
France2024: 499.80M 2025: 513.28M
Germany2024: 169.89M 2025: 163.91M
Italy2024: 180.10M 2025: 201.90M
Other Europe2024: 748.30M 2025: 788.07M
Other Foreign Countries2024: 619.55M 2025: 648.79M
Spain2024: 171.78M 2025: 195.41M
United States2024: 1.04B 2025: 1.07B
Beauty2024: 1.23B 2025: 1.31B
Closures2024: 714.01M 2025: 730.26M
Pharma2024: 1.64B 2025: 1.74B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.40%2.1M62.2M463.25K
2026-10-153.32%2.1M62.4M459.65K
2026-09-303.35%2.1M62.4M447.76K
2026-09-153.11%1.9M62.4M453.25K
2026-08-312.67%1.7M62.4M460.05K
2026-08-142.56%1.6M62.4M478.56K
2026-07-312.93%1.8M62.7M520.06K
2026-07-152.92%1.8M62.9M508.90K
2026-06-302.92%1.8M62.9M503.17K
2026-06-153.63%2.3M62.9M510.63K
2026-05-292.88%1.8M62.9M515.61K
2026-05-152.95%1.9M62.9M518.05K
2026-04-302.43%1.5M63.3M531.92K
2026-04-152.37%1.5M63.2M523.38K
2026-03-312.29%1.5M63.8M530.86K
2026-03-132.00%1.3M63.8M517.86K
2026-02-272.03%1.3M63.8M526.73K
2026-02-131.85%1.2M63.8M546.74K
2026-01-301.89%1.2M65.0M577.83K
2026-01-151.88%1.2M65.0M585.09K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call75.0066.3069.200.002.8200.000.000.969-0.2130.016
call80.0060.9064.400.002.5780.000.000.966-0.2100.017
call85.0056.3059.2041.002.3501.000.000.963-0.2060.018
call90.0051.7054.400.002.1340.000.000.959-0.2030.019
call95.0046.7049.400.001.9290.000.000.955-0.1990.021
call10041.4044.4025.851.7323.000.000.950-0.1940.023
call10536.7039.4024.501.5431.000.000.944-0.1880.025
call11031.1034.200.001.3600.000.000.937-0.1820.028
call11526.1029.2018.501.1821.000.000.928-0.1750.031
call12021.7024.2018.201.00829.000.000.917-0.1660.034
call12516.1019.2016.000.8357.000.000.901-0.1560.039
call13011.2014.2014.950.66214.000.000.791-0.2930.064
call1356.809.405.000.53014.000.000.729-0.2640.074
call1403.005.603.650.45712.000.000.613-0.2500.086
call1450.203.602.150.5112.000.000.443-0.2610.088
call1500.002.801.800.6211.000.000.319-0.2720.080
call1550.002.301.500.7201.000.000.252-0.2880.071
call1600.000.750.000.5920.000.000.120-0.1480.045
call1650.000.750.000.7050.000.000.104-0.1600.040
call1700.000.750.000.8070.000.000.094-0.1690.037
call1750.001.751.230.9031.000.000.086-0.1760.035
call1800.000.750.000.9940.000.000.079-0.1830.033
call1850.000.500.200.91810.000.000.057-0.1270.027
put75.000.002.150.402.4396.000.00-0.031-0.2100.016
put80.000.000.750.002.2250.000.00-0.034-0.2060.017
put85.000.001.750.002.0240.000.00-0.037-0.2020.018
put90.000.001.751.851.8331.000.00-0.040-0.1980.019
put95.000.000.752.681.6542.000.00-0.045-0.1930.021
put1000.001.751.151.4807.000.00-0.050-0.1880.023
put1050.002.151.801.3137.000.00-0.055-0.1820.025
put1100.001.750.851.1482.000.00-0.063-0.1750.028
put1150.000.750.050.9934.000.00-0.071-0.1680.031
put1200.002.150.100.83611.000.00-0.083-0.1580.034
put1250.000.754.400.6878.000.00-0.099-0.1470.039
put1300.002.301.200.8081.000.00-0.209-0.2840.064
put1350.002.6513.650.6592.000.00-0.267-0.2530.074
put1400.203.602.980.5313.000.00-0.401-0.2410.086
put1453.006.003.030.5361.000.00-0.557-0.2500.088
put1506.609.500.000.5600.000.00-0.680-0.2610.080
put15511.3014.400.000.7080.000.00-0.748-0.2760.071
put16016.3019.400.000.8520.000.00-0.880-0.1360.045
put16521.3024.400.000.9840.000.00-0.895-0.1460.041
put17026.3029.400.001.1060.000.00-0.906-0.1550.037
put17531.3034.400.001.2210.000.00-0.914-0.1620.035
put18036.3039.200.001.2910.000.00-0.920-0.1680.033
put18541.3044.200.001.3920.000.00-0.944-0.1240.025

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-064Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-09-218-KCurrent report2026-09-21SEC
2026-09-113Initial statement of beneficial ownership of securities2026-09-11SEC
2026-09-108-KCurrent report2026-09-04SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-024Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-018-KCurrent report2026-08-29SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-08-27144Filing for proposed sale of securities under Rule 144.SEC
2026-08-12SCHEDULE 13G/ASEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-04144Filing for proposed sale of securities under Rule 144.SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-03144Filing for proposed sale of securities under Rule 144.SEC
2026-08-03144Filing for proposed sale of securities under Rule 144.SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-07-3110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-308-KCurrent report2026-07-30SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-16SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-16SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-16SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-16SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-16SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-16SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-16SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100283.97K1
2026-100000
2026-090099.73K1
2026-08003.51M4
2026-070000
2026-0600978.24K2
2026-0500643.78K2
2026-040000
2026-030000
2026-0200770.36K2
2026-010000
2025-12001.82M1
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.9.62%
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO7.43%
VANGUARD PORTFOLIO MANAGEMENT LLC5.70%
MORGAN STANLEY5.52%
VANGUARD CAPITAL MANAGEMENT LLC4.53%
STATE STREET CORP4.49%
VICTORY CAPITAL MANAGEMENT INC4.38%
DIMENSIONAL FUND ADVISORS LP2.97%
GEODE CAPITAL MANAGEMENT, LLC2.73%
Neuberger Berman Group LLC2.43%

Funds

Fund% owned
TCW METWEST TOTAL RETURN BOND FUND23.58%
Baird Core Plus Bond Fund22.96%
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND15.97%
Baird Aggregate Bond Fund11.75%
Victory Income Fund11.08%
VANGUARD TOTAL BOND MARKET INDEX FUND10.67%
Thornburg Strategic Income Fund10.50%
VANGUARD TOTAL BOND MARKET II INDEX FUND9.42%
Thornburg Limited Term Income Fund7.16%
iShares iBonds Dec 2031 Term Corporate ETF5.83%

OakChart. ATR. Cached 15 minutes.